[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$lxeos
Positive community sentiment is driving the price up. Market volatility remains a concern for investors.
About $lxeos
A cryptocurrency.
Insights #
- $lxeos engagements is up XXXXXX% from the previous week.
Engagements: XX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX +929%
1 Month: XX -XX%
1-Year High: XXXXX on 2025-08-15
1-Year Low: X on 2025-08-20
| Social Network | X |
|---|---|
| Engagements | XX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-10-13
1-Year Low: X on 2025-08-15
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $lxeos in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1-Year High: X on 2025-08-15
1-Year Low: X on 2025-08-15
The most influential creators that mention $lxeos in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Quantumup1 | X | XXXXX | X | XX |
Top assets mentioned In the posts about $lxeos in the last XX hours
Biogen Inc (BIIB) Biogen Inc (BIIB) PTC Therapeutics, Inc. (PTCT)
Top topics mentioned In the posts about $lxeos in the last XX hours
$lrmr, $lxeo, biogen inc, stocks healthcare, $biib, $rckt, $tnya, $ptct
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"H.C. Wainwrightthe PT on $LXEO to $XX from $X plusLX2006's odds of approval to XX% from XX% and movedthe expected launch to 2028 from 2030 after the Co📰that the FDA has indicated openness to a BLA submission for accelerated approval (AA); reiterated Buy. $LRMR $BIIB"
X Link @Quantumup1 2025-10-07T15:29Z 3826 followers, 2518 engagements
"H.C. Wainwright $LXEO's PT to $X from $XX (Dilution Related - Modified OP Expenses) reit'd at Buy and says that it views 'LX2020 is nearing its 2H25 interim readout in a risk-mitigated position.' $RCKT $TNYA $LRMR $PTCT $BIIB H.C. Wainwright said in its note: Lexeo disclosed that eight patients have now been dosed in the Phase 1/2 (HEROIC-PKP2) trial of LX2020 spanning three cohorts-low dose (n=3) high dose (n=3) and high-dose expansion (n=2)-with interim data expected in 2H25. We believe LX2020 is positioned well in lieu of competitor data from Rocket Pharmaceuticals' ( $RCKT; not rated)"
X Link @Quantumup1 2025-08-15T15:05Z 3826 followers, 4235 engagements